Town and Country-based Defender Pharmaceuticals inks deal with U.S. Army to develop tropical disease vaccines


Defender Pharmaceuticals said Monday it has entered into an exclusive license agreement with part of the U.S. Army Medical Research and Development Command to develop and commercialize eight vaccines for tropical diseases.

Previous Women Who Lead in Transportation: Erica Plybeah Hemphill of MedHaul
Next Cleveland Clinic leads $17.6 million investment in deep brain stimulation therapy